Meeting of the National Advisory Council for Healthcare Research and Quality, 12228 [2017-03998]

Download as PDF 12228 Federal Register / Vol. 82, No. 39 / Wednesday, March 1, 2017 / Notices indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than March 22, 2017. A. Federal Reserve Bank of St. Louis (David L. Hubbard, Senior Manager) P.O. Box 442, St. Louis, Missouri 63166–2034. Comments can also be sent electronically to Comments.applications@stls.frb.org: 1. Cross County Bancshares, Inc., Wynne, Arkansas; to acquire additional shares, for a total of 24.9 percent of Central Bank, Little Rock, Arkansas. Board of Governors of the Federal Reserve System, February 24, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–03938 Filed 2–28–17; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Friday, March 24, 2017, from 8:30 a.m. to 2:45 p.m. ADDRESSES: The meeting will be held at the Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:09 Feb 28, 2017 Jkt 241001 Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Alison Hunt at (301) 427– 1244 or Alison.Hunt@ahrq.hhs.gov. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Friday, March 17, 2017. The agenda, roster, and minutes will be available from Ms. Bonnie Campbell, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland, 20857. Ms. Campbell’s phone number is (301) 427–1554. www.AHRQ.gov no later than Friday, March 17, 2017. SUPPLEMENTARY INFORMATION: SUMMARY: I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda The Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public and will be available via webcast at www.webconferences.com/ahrq. The meeting will begin with an update on AHRQ’s current research, programs, and initiatives. The agenda will feature discussions on the learning health care system, Medical Expenditure Panel Survey (MEPS), and AHRQ’s work in rural areas. The final agenda will be available on the AHRQ Web site at PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Sharon B. Arnold, Acting Director. [FR Doc. 2017–03998 Filed 2–28–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Expired Listing From the Surgical Momentum PSO Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of delisting. AGENCY: The Patient Safety and Quality Improvement Act of 2005, 42 U.S.C. 299b–21 to b–26, (Patient Safety Act) and the related Patient Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient Safety Rule), published in the Federal Register on November 21, 2008, 73 FR 70732– 70814, establish a framework by which hospitals, doctors, and other health care providers may voluntarily report information to Patient Safety Organizations (PSOs), on a privileged and confidential basis, for the aggregation and analysis of patient safety events. The Patient Safety Rule authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. The listing from the Surgical Momentum PSO has expired and AHRQ has delisted the PSO accordingly. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12:00 Midnight ET (2400) on January 21, 2017. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: https:// www.pso.ahrq.gov/listed. FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 82, Number 39 (Wednesday, March 1, 2017)]
[Notices]
[Page 12228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03998]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a) of the Federal Advisory 
Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the 
National Advisory Council for Healthcare Research and Quality.

DATES: The meeting will be held on Friday, March 24, 2017, from 8:30 
a.m. to 2:45 p.m.

ADDRESSES: The meeting will be held at the Hubert H. Humphrey Building, 
Room 800, 200 Independence Avenue SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Alison Hunt at 
(301) 427-1244 or Alison.Hunt@ahrq.hhs.gov.
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact the Food and Drug 
Administration (FDA) Office of Equal Employment Opportunity and 
Diversity Management on (301) 827-4840, no later than Friday, March 17, 
2017. The agenda, roster, and minutes will be available from Ms. Bonnie 
Campbell, Committee Management Officer, Agency for Healthcare Research 
and Quality, 5600 Fishers Lane, Rockville, Maryland, 20857. Ms. 
Campbell's phone number is (301) 427-1554.

SUPPLEMENTARY INFORMATION:

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director of AHRQ on matters related to AHRQ's conduct of its 
mission including providing guidance on (A) priorities for health care 
research, (B) the field of health care research including training 
needs and information dissemination on health care quality and (C) the 
role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    The Council meeting will convene at 8:30 a.m., with the call to 
order by the Council Chair and approval of previous Council summary 
notes. The meeting is open to the public and will be available via 
webcast at www.webconferences.com/ahrq. The meeting will begin with an 
update on AHRQ's current research, programs, and initiatives. The 
agenda will feature discussions on the learning health care system, 
Medical Expenditure Panel Survey (MEPS), and AHRQ's work in rural 
areas. The final agenda will be available on the AHRQ Web site at 
www.AHRQ.gov no later than Friday, March 17, 2017.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-03998 Filed 2-28-17; 8:45 am]
BILLING CODE 4160-90-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.